Apoptotic effects of dietary and synthetic sphingolipids in androgen-independent (PC-3) prostate cancer cells

Lipids

Volumn 43, Issue 2, 2008, Pages 143-149

  Kent, Kyle D ^a   Clubbs, Elizabeth A ^a   Harper, W James ^a   Bomser, Joshua A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cancer; Ceramide; Prostate; Sphingomyelin

Indexed keywords

ANDROGEN; CERAMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RETINOBLASTOMA PROTEIN; SPHINGOLIPID; SPHINGOMYELIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIPID METABOLISM; PROSTATE CANCER; SIGNAL TRANSDUCTION;

ANDROGENS; APOPTOSIS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CERAMIDES; DIET; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROSTATIC NEOPLASMS; SPHINGOLIPIDS; TUMOR CELLS, CULTURED;

EID: 42549091692     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-007-3148-z     Document Type: Article

References (32)

1. American Cancer Society (2007) Facts and figures. http://www.cancer.org
2. Kolesnick R (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110:3-8
3. Mimeault M (2002) New advances on structural and biological functions of ceramide in apoptotic/necrotic cell death and cancer. FEBS Lett 530:9-16
4. Molkentin J (1999) Bioactive lipids naturally occurring in bovine milk. Nahrung 431:185-189
5. Parodi PW (1999) Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat. J Dairy Sci 82:1339-1349
6. Tepper AD, Diks SH, van Blitterswijk WJ, Borst J (2000) Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens. J Biol Chem 275:34810-34817
7. van Blitterswijk WJ, van der Luit A, Veldman RJ, Verheij M, Borst J (2003) Ceramide: second messenger or modulator of membrane structure and dynamics? J Biochem 369:199-211
8. Padron JM (2006) Sphingolipids in anticancer therapy. Curr Med Chem 13:755-770
9. Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, Iwai K, Tashima M, Uchiyama T, Okazaki T (2003) Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia. Clin Cancer Res 8:415-423
10. Kester M, Kolesnick R (2003) Sphingolipids as therapeutics. Pharmacol Res 47:365-371
11. Reynolds CP, Maurer BJ, Kolesnick RN (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206:169-180
12. Selzner M, Bielawska A, Morse MA, Rüdiger HA, Sindram D, Hannum YA, Clavien PA (2001) Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61:1233-1240
13. Senchekov A, Litvak DA, Cabot MC (2001) Targeting ceramide metabolism - a strategy for overcoming drug resistance. J Natl Canc Inst 93:347-357
14. Wang XZ, Beebe JR, Pwiti L, Bielawska A, Smyth MJ (1999) Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res 59:5842-5848
15. Lemonnier LA, Dillehay DL, Vespremi MJ, Abrams J, Brody E, Schmelz EM (2003) Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys 419:129-138
16. Silins I, Nordstrand M, Högberg J, Stenius U (2003) Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo. Carcinogenesis 24:1077-1083
17. Wang X, Clubbs EA, Bomser JA (2006) Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways. J Nutr Biochem 17:204-210
18. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808
19. Ahn EH, Schroeder JJ (2002a) Bioactive sphingolipids are constituents of soy and dairy products. J Food Sci 67:522-524
20. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E (1997) Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142:208-225
21. Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH Jr (1999) Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 129:1239-1250
22. Schiller J, Zschörnig O, Petković M, Müller M, Arnhold J, Arnold K (2001) Lipid analysis of human HDL and LDL by MALDI-TOF mass spectrometry and 31P-NMR. J Lipid Res 42:1501-1508
23. Seelan RS, Qian C, Yokomizo A, Bostwick DG, Smith DI, Liu W (2000) Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer 29:137-146
24. Oh JE, So KS, Lim SJ, Kim Y (2006) Induction of apoptotic cell death by a ceramide analog in PC-3 prostate cancer cells. Arch Pharm Res 29:1140-1146
25. Shabbits JA, Mayer LD (2003) Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro. Biochim Biophys Acta 1612:98-106
26. Bourbon NA, Yun J, Berkey D, Wang Y, Kester M (2001) Inhibitory actions of ceramide upon PKC-ε/ERK interactions. Am J Physiol Cell Physiol 280:C1403-C1411
27. Coroneos E, Wang Y, Panuska JR, Templeton DJ, Kester M (1996) Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. J Biochem 316:13-17
28. Jarvis WD, Fornari FA Jr, Auer KL, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent P, Grant S (1997) Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol 52:935-947
29. Ragg SJ, Kaga S, Berg KA, Ochi A (1998) The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J Immunol 161:1390-1398
30. Jayadev S, Liu B, Bielawska AE, Lee JY, Nazaire F, Pushkareva MY, Obeid LM, Hannun YA (1995) Role for ceramide in cell cycle arrest. J Biol Chem 270:2047-2052
31. Ogretmen B, Pettus BJ, Rossi MJ, Wood R, Usta J, Szulc Z, Bielawska A, Obeid LM, Hannun YA (2002) Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. J Biol Chem 277:12960-12969
32. Oberhammer FA, Hochegger K, Froschl G, Tiefenbacher R, Pavelka M (1994) Chromatin condensation during apoptosis is accompanied by degradation of lamin A + B, without enhanced activation of cdc2 kinase. J Cell Biol 126:827-837